Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-06-10 Purchase |
2022-06-13 4:05 pm |
Lyra Therapeutics Inc. | LYRA | MERRIFIELD C ANN Director |
4,000 | $5.05 | $20,200 | 11,328 (Direct) |
View |
| 2022-05-13 Purchase |
2022-05-17 5:35 pm |
Lyra Therapeutics Inc. | LYRA | MERRIFIELD C ANN Director |
3,828 | $4.829 | $18,486 | 7,328 (Direct) |
View |
| 2022-04-12 Purchase |
2022-04-14 4:53 pm |
Lyra Therapeutics Inc. | LYRA | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD Perceptive LS (A) LLC EDELMAN JOSEPH Director 10% Owner |
5,924,170 | $4.22 | $24,999,997 | 9,146,731 (Indirect) |
View |
| 2022-04-12 Purchase |
2022-04-14 4:14 pm |
Lyra Therapeutics Inc. | LYRA | NBVM GP LLC DAMORE RICHARD A NORTH BRIDGE VENTURE PARTNERS V A LP NORTH BRIDGE VENTURE PARTNERS V-B LP North Bridge Venture Partners VI L P North Bridge Venture Management V L.P. North Bridge Venture Management VI L.P. 10% Owner |
2,369,667 | $4.22 | $9,999,995 | 1,318,133 (Indirect) |
View |
| 2022-04-12 Purchase |
2022-04-14 4:08 pm |
Lyra Therapeutics Inc. | LYRA | ANDERSON EDWARD T Director 10% Owner |
2,488,150 | $4.22 | $10,499,993 | 1,436,616 (Indirect Direct) |
View |
| 2022-04-12 Purchase |
2022-04-13 7:16 pm |
Lyra Therapeutics Inc. | LYRA | Waksal Harlan Executive Chair |
236,966 | $4.22 | $999,997 | 236,966 (Direct) |
View |
| 2021-06-17 Purchase |
2021-06-22 4:28 pm |
Lyra Therapeutics Inc. | LYRA | MERRIFIELD C ANN Director |
3,500 | $8.9699 | $31,395 | 3,500 (Direct) |
View |
| 2020-12-16 Purchase |
2020-12-17 4:05 pm |
Lyra Therapeutics Inc. | LYRA | snyderman nancy lynn MD Director |
1,025 | $9.72 | $9,963 | 1,025 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-06-16 Option Award |
2022-06-21 4:06 pm |
N/A 2032-06-15 |
Lyra Therapeutics Inc. | LYRA | MERRIFIELD C ANN Director |
7,250 | $0 | 7,250 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-21 4:06 pm |
N/A 2032-06-15 |
Lyra Therapeutics Inc. | LYRA | ALTMAN MICHAEL SETH Director |
7,250 | $0 | 7,250 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-21 4:06 pm |
N/A 2032-06-15 |
Lyra Therapeutics Inc. | LYRA | Smith W Bradford Director |
7,250 | $0 | 7,250 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-21 4:06 pm |
N/A 2032-06-15 |
Lyra Therapeutics Inc. | LYRA | Poukalov Konstantin Director |
7,250 | $0 | 7,250 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-21 4:06 pm |
N/A 2032-06-15 |
Lyra Therapeutics Inc. | LYRA | Waksal Harlan Executive Chair |
953,002 | $0 | 953,002 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-21 4:05 pm |
N/A 2032-06-15 |
Lyra Therapeutics Inc. | LYRA | ANDERSON EDWARD T Director 10% Owner |
7,250 | $0 | 7,250 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-21 4:05 pm |
N/A 2032-06-15 |
Lyra Therapeutics Inc. | LYRA | snyderman nancy lynn MD Director |
7,250 | $0 | 7,250 (Direct) |
View |
| 2022-03-04 Option Award |
2022-03-08 4:26 pm |
N/A 2032-03-03 |
Lyra Therapeutics Inc. | LYRA | TOBIN JAMES R Director |
14,500 | $0 | 14,500 (Direct) |
View |
| 2022-02-16 Option Award |
2022-02-18 5:12 pm |
N/A 2032-02-15 |
Lyra Therapeutics Inc. | LYRA | Palasis Maria President & CEO |
175,000 | $0 | 175,000 (Direct) |
View |
| 2022-02-16 Option Award |
2022-02-18 5:09 pm |
N/A 2032-02-15 |
Lyra Therapeutics Inc. | LYRA | Waksal Harlan Executive Chair |
520,000 | $0 | 520,000 (Direct) |
View |
| 2022-02-12 Option Award |
2022-02-15 9:31 pm |
N/A 2032-02-11 |
Lyra Therapeutics Inc. | LYRA | Noyes Corinne See Remarks |
32,000 | $0 | 32,000 (Direct) |
View |
| 2022-02-12 Option Award |
2022-02-15 9:31 pm |
N/A 2032-02-11 |
Lyra Therapeutics Inc. | LYRA | Palasis Maria President & CEO |
127,400 | $0 | 127,400 (Direct) |
View |
| 2022-02-12 Option Award |
2022-02-15 9:30 pm |
N/A 2032-02-11 |
Lyra Therapeutics Inc. | LYRA | Nelson Pamela E. SVP, Regulatory Affairs |
30,000 | $0 | 30,000 (Direct) |
View |
| 2022-02-12 Option Award |
2022-02-15 9:30 pm |
N/A 2032-02-11 |
Lyra Therapeutics Inc. | LYRA | Cavalier Jason Chief Financial Officer |
15,605 | $0 | 15,605 (Direct) |
View |
| 2022-02-12 Option Award |
2022-02-15 9:30 pm |
N/A 2032-02-11 |
Lyra Therapeutics Inc. | LYRA | Richard Robert E. SVP, Technical Operations |
35,000 | $0 | 35,000 (Direct) |
View |
| 2021-09-13 Option Award |
2021-09-15 5:44 pm |
N/A 2031-09-12 |
Lyra Therapeutics Inc. | LYRA | Cavalier Jason Chief Financial Officer |
104,000 | $0 | 104,000 (Direct) |
View |
| 2021-05-26 Option Award |
2021-05-28 6:28 pm |
N/A 2031-05-25 |
Lyra Therapeutics Inc. | LYRA | ALTMAN MICHAEL SETH Director |
7,250 | $0 | 7,250 (Direct) |
View |
| 2021-05-26 Option Award |
2021-05-28 6:25 pm |
N/A 2031-05-25 |
Lyra Therapeutics Inc. | LYRA | Poukalov Konstantin Director |
7,250 | $0 | 7,250 (Direct) |
View |
| 2021-05-26 Option Award |
2021-05-28 6:24 pm |
N/A 2031-05-25 |
Lyra Therapeutics Inc. | LYRA | snyderman nancy lynn MD Director |
7,250 | $0 | 7,250 (Direct) |
View |
| 2021-05-26 Option Award |
2021-05-28 6:24 pm |
N/A 2031-05-25 |
Lyra Therapeutics Inc. | LYRA | MERRIFIELD C ANN Director |
7,250 | $0 | 7,250 (Direct) |
View |
| 2021-05-26 Option Award |
2021-05-28 6:23 pm |
N/A 2031-05-25 |
Lyra Therapeutics Inc. | LYRA | Smith W Bradford Director |
7,250 | $0 | 7,250 (Direct) |
View |
| 2021-05-26 Option Award |
2021-05-28 6:23 pm |
N/A 2031-05-25 |
Lyra Therapeutics Inc. | LYRA | ANDERSON EDWARD T Director |
7,250 | $0 | 7,250 (Direct) |
View |
| 2021-02-08 Option Award |
2021-02-10 4:05 pm |
N/A 2031-02-07 |
Lyra Therapeutics Inc. | LYRA | Elsey R Don CFO, Treasurer & Secretary |
45,000 | $0 | 45,000 (Direct) |
View |
| 2021-02-08 Option Award |
2021-02-10 4:05 pm |
N/A 2031-02-07 |
Lyra Therapeutics Inc. | LYRA | Palasis Maria President & CEO |
120,000 | $0 | 120,000 (Direct) |
View |
| 2021-02-08 Option Award |
2021-02-10 4:05 pm |
N/A 2031-02-07 |
Lyra Therapeutics Inc. | LYRA | Noyes Corinne See Remarks |
30,000 | $0 | 30,000 (Direct) |
View |
| 2021-02-08 Option Award |
2021-02-10 4:05 pm |
N/A 2031-02-07 |
Lyra Therapeutics Inc. | LYRA | Nelson Pamela E. Senior VP, Regulatory Affairs |
13,000 | $0 | 13,000 (Direct) |
View |
| 2021-02-08 Option Award |
2021-02-10 4:05 pm |
N/A 2031-02-07 |
Lyra Therapeutics Inc. | LYRA | Richard Robert E. SVP of R&D |
18,000 | $0 | 18,000 (Direct) |
View |
| 2020-10-27 Option Award |
2020-10-29 8:45 pm |
N/A 2030-10-26 |
Lyra Therapeutics Inc. | LYRA | snyderman nancy lynn MD Director |
14,500 | $0 | 14,500 (Direct) |
View |